Sigrid S. Skånland

Centre for Molecular Medicine Norway (NCMM),

Nordic EMBL Partnership,

K. G. Jebsen Centre for B cell malignancies and K. G. Jebsen Centre for Cancer Immunotherapy,

Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership

University of Oslo